StreetInsider.com News Articles

Form 4 IRIDEX CORP For: Aug 24 Filed by: Dizon Romeo R

Mon, 24 Aug 2026 12:03:00 -0400

si-local-file:///var/storage/secattach/20260824/26966439.html

Form 4 IRIDEX CORP For: Aug 24 Filed by: Dizon Romeo R

Mon, 24 Aug 2026 12:03:00 -0400

si-local-file:///var/storage/secattach/20260824/26966439.html

Form 10-Q IRIDEX CORP For: Jul 04

Tue, 18 Aug 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260818/26945156.html

Form 10-Q IRIDEX CORP For: Jul 04

Tue, 18 Aug 2026 16:54:00 -0400

si-local-file:///var/storage/secattach/20260818/26945156.html

Form 8-K IRIDEX CORP For: Aug 18

Tue, 18 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260818/26945124.html

Form 8-K IRIDEX CORP For: Aug 18

Tue, 18 Aug 2026 16:51:00 -0400

si-local-file:///var/storage/secattach/20260818/26945124.html

Iridex Corp (IRIX) Misses Q2 EPS by 5c

Tue, 18 Aug 2026 16:26:16 -0400

Iridex Corp (NASDAQ: IRIX) reported Q2 EPS of ($0.07), $0.05 worse than the analyst estimate of ($0.02). Revenue for the quarter came in at $12.6 million versus the consensus estimate of $14.13 million.

For earnings history and earnings-related data on Iridex Corp (IRIX) click here.

Iridex Reports Second Quarter 2026 Financial Results

Tue, 18 Aug 2026 16:05:00 -0400

MOUNTAIN VIEW, Calif., Aug. 18, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today reported financial results for the second quarter ended July 4, 2026.

Second Quarter 2026 Financial Highlights

Generated total revenue of $12.6 million, compared to $13.6 million in the prior year period
Cyclo G6^® product family revenue was $3.9 million, representing growth of 19% year-over-year compared to $3.3 million in the prior year period
- Sold 17,700 Cyclo G6 probes compared to 13,100

Iridex Reports Second Quarter 2026 Financial Results

Tue, 18 Aug 2026 16:05:00 -0400

Second Quarter 2026 Financial Highlights

Generated total revenue of $12.6 million, compared to $13.6 million in the prior year period
Cyclo G6^® product family revenue was $3.9 million, representing growth of 19% year-over-year compared to $3.3 million in the prior year period
- Sold 17,700 Cyclo G6 probes compared to 13,100

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

Tue, 04 Aug 2026 16:05:00 -0400

MOUNTAIN VIEW, Calif., Aug. 04, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced plans to release financial results for the second quarter 2026 and provide a business update after the close of trading on August 18, 2026.

The Company’s management team will host a corresponding conference call beginning at 2:00 p.m. PT / 5:00 p.m. ET. Investors interested in listening to the conference call may do so by dialing +1-800-715-9871 from the US

Iridex to Report Second Quarter 2026 Financial Results on August 18, 2026

Tue, 04 Aug 2026 16:05:00 -0400

Iridex adds EndoProbe handpieces to EyeProGPO product lineup

Mon, 20 Jul 2026 07:03:07 -0400

Iridex Corporation (Nasdaq: IRIX) announced the expansion of its EyeProGPO product offering to include its line of EndoProbe Handpieces, according to a press release issued July 20, 2026.

Through the agreement, more than 4,300 EyeProGPO members will have access to preferred pricing on Iridex EndoProbe Handpieces. The members include ophthalmology practices, ambulatory surgery centers, and hospitals across the United States.

EndoProbe Handpieces are single-use devices indicated for use with Iridex laser consoles for the treatment of retinal disorders in adult patients. The portfolio includes straight, angled, stepped-angled, illuminating, and adjustable models, with configurations available in 20G, 23G, and 25G, and select stepped

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

Mon, 20 Jul 2026 07:00:00 -0400

MOUNTAIN VIEW, Calif., July 20, 2026 (GLOBE NEWSWIRE) -- Iridex Corporation (Nasdaq: IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced the expansion of its EyeProGPO product offering to include the Company’s line of EndoProbe^®Handpieces.

Through the agreement, more than 4,300 EyeProGPO members will have access to preferred pricing on Iridex EndoProbe Handpieces, expanding the value Iridex provides to ophthalmology practices, ambulatory surgery centers, and hospitals across the United States. The addition builds on Iridex’s existing EyeProGPO product offering, which

Iridex Adds EndoProbe® Handpieces to EyeProGPO Product Offering

Mon, 20 Jul 2026 07:00:00 -0400

Form 8-K IRIDEX CORP For: Jul 10

Thu, 16 Jul 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260716/26776061.html

Form 8-K IRIDEX CORP For: Jul 10

Thu, 16 Jul 2026 06:05:00 -0400

si-local-file:///var/storage/secattach/20260716/26776061.html

Form 4 IRIDEX CORP For: Jul 10 Filed by: Mercer Patrick

Tue, 14 Jul 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260714/26768913.html

Form 4 IRIDEX CORP For: Jul 10 Filed by: Mercer Patrick

Tue, 14 Jul 2026 16:59:00 -0400

si-local-file:///var/storage/secattach/20260714/26768913.html

Form 4 IRIDEX CORP For: Jul 10 Filed by: Dizon Romeo R

Tue, 14 Jul 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260714/26768710.html

Form 4 IRIDEX CORP For: Jul 10 Filed by: Dizon Romeo R

Tue, 14 Jul 2026 16:39:00 -0400

si-local-file:///var/storage/secattach/20260714/26768710.html

Form SCHEDULE 13D/A IRIDEX CORP Filed by: Novel Inspiration International Co., Ltd.

Mon, 13 Jul 2026 17:50:00 -0400

si-local-file:///var/storage/secattach/20260713/26763373.html

Form SCHEDULE 13D/A IRIDEX CORP Filed by: Novel Inspiration International Co., Ltd.

Mon, 13 Jul 2026 17:50:00 -0400

si-local-file:///var/storage/secattach/20260713/26763373.html

Form 4 IRIDEX CORP For: Jul 07 Filed by: Novel Inspiration International Co., Ltd.

Wed, 08 Jul 2026 08:44:00 -0400

si-local-file:///var/storage/secattach/20260708/26744927.html

Form 4 IRIDEX CORP For: Jul 07 Filed by: Novel Inspiration International Co., Ltd.

Wed, 08 Jul 2026 08:44:00 -0400

si-local-file:///var/storage/secattach/20260708/26744927.html

Form 8-K IRIDEX CORP For: Jun 12

Thu, 18 Jun 2026 16:15:00 -0400

si-local-file:///var/storage/secattach/20260618/26666201.html